Atlas Trials

Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer

Clinical trial NCT07219303 · RECRUITING

Trial details

NCT number
NCT07219303
Sponsor
Fox Chase Cancer Center
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Cancer (Adenocarcinoma)
Start date
2025-09-25
Primary completion
2033-08-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.